Insilico and TaiGen Celebrate Clinical Milestone for CKD Anemia Treatment ISM4808 Insilico Medicine and TaiGen Biotechnology announce the successful completion of first human enrollment for ISM4808, a new CKD anemia treatment.

Insilico and TaiGen Celebrate Clinical Milestone for CKD Anemia Treatment ISM4808 #None #Insilico_Medicine #CKD_Anemia #TaiGen_Biotechnology